WO2023067519 - TOPICAL COMPOSITIONS AND METHODS FOR PHOTODYNAMIC THERAPY
National phase entry:
Publication Number
WO/2023/067519
Publication Date
27.04.2023
International Application No.
PCT/IB2022/060058
International Filing Date
19.10.2022
Title **
[English]
TOPICAL COMPOSITIONS AND METHODS FOR PHOTODYNAMIC THERAPY
[French]
COMPOSITIONS TOPIQUES ET PROCÉDÉS DE THÉRAPIE PHOTODYNAMIQUE
Applicants **
SUN PHARMACEUTICAL INDUSTRIES, INC.
Inventors
SANGHVI, Pradeep
LUNDAHL, Scott
JIN, Xiaopin
HADJIKEZIAN, Brenden B.
ZADYKOWICZ, Jerzy
ABDALGHAFOR, Haydar
HAQUE, Tasnuva
Priority Data
63/257,175
19.10.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3556 | |
| EPO | Filing, Examination, Granting | 34862 | |
| Japan | Filing, Examination, Granting | 3418 | |
| South Korea | Filing, Examination, Granting | 4634 | |
| USA | Filing, Examination, Granting | 13140 |
Total:
59,610
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Methods and topical compositions for the treatment of a dermatological disorder are provided. The topical composition includes 5-aminolevulinic acid, at least one penetration enhancer and at least one chelating agent. Further, methods and topical compositions for use in photodynamic therapy are disclosed, in which the topical composition is applied to the affected area of a patient for a period in the range of about 15 minutes to about 10 hours.[French]
L'invention concerne des procédés et des compositions topiques pour le traitement d'un trouble dermatologique. La composition topique comprend de l'acide 5-aminolévulinique, au moins un activateur de pénétration et au moins un agent chélatant. En outre, l'invention concerne des procédés et des compositions topiques destinés à être utilisés en thérapie photodynamique, la composition topique étant appliquée sur la zone affectée d'un patient pendant une période allant d'environ 15 minutes à environ 10 heures.